Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Over the next few weeks, Im going to be doing a 3-part series, examining GLP-1 receptor agonists
Get up frequently while sitting
Parents can drop their kids off with trained caregivers while they head into reformer classes, eliminating one of the biggest barriers to working out
It is known as a GLP-1 receptor agonist
Currently Available Treatment Tirzepatide FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential Retatrutide Phase 3 TRIUMPH-4 data showed 28.7% weight loss at 68 weeks (24.2% at 48 weeks in Phase 2), exceeding tirzepatide's results Non-Alcoholic Fatty Liver Disease Retatrutide Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management Tirzepatide Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly
US$ 20.47
US$ 24.36
US$ 29.96
US$ 20.67
